ArticleHeliyon2023

Synergistic anti-tumour activity of sorafenib in combination with pegylated resveratrol is mediated by Akt/mTOR/p70S6k-4EBP-1 and c-Raf7MEK/ERK signaling pathways.

Ligang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.